|

Darolutamide (BAY1841788) Clinical Trials

1 actively recruiting trial

Also known as: ODM-201

Pipeline

Phase 2: 1

Top Sponsors

  • Sir Mortimer B. Davis - Jewish General Hospital1

Indications

  • Castration-resistant Prostate Cancer1
  • Metastatic Prostate Cancer1
  • Cancer1

Other1 trial

Management of Oligoprogressive Castration Resistant Prostate Cancer (PCS X)
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.